TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...

TriLink BioTechnologies, a Maravai LifeSciences company (MRVI), has partnered with, Avantor (AVTR) to expand availability of its innovative ...

TriLink BioTechnologies, a Maravai LifeSciences company and provider of life science reagents and services, has partnered ...

A recent study described develops methods for synthesizing and quantifying metal-induced glycation products, particularly in ...

Despite hosting more oncology start-ups, Europe is lagging in the development of cancer technologies, losing the competitive ...

Genetic medicines could treat certain diseases, however, the current delivery systems available—viral vectors and lipid nanoparticles (LNPs)—pose unique challenges for gene therapy applications. For ...

Advance quantum information systems through innovative material design. Develop ultrasensitive biosensors for non-invasive ...

Intelligent Bio Solutions Inc. (NASDAQ:INBS – Get Free Report) saw a significant drop in short interest during the month of January. As of January 15th, there was short interest totalling 427,400 ...

There are notable differences between men and women in their susceptibility to many human diseases, including cardiovascular ...

KBR announced today its participation in upcoming February 2025 investor conferences. TD Cowen 46th Annual Aerospace and ...

MIAMI, Feb. 3, 2025 /PRNewswire-PRWeb/ -- kluster.ai, the decentralized AI platform, became the first to market to host DeepSeek-R1. The model matches OpenAI's performance in logic, mathematics, and ...

In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report).